📰 Genuv Inc News
Genuv Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genuv Inc. Real-time updates on events, politics, business and more.
August 29, 2023
(Albany, United States) As per DelveInsight’s assessment, globally, the Amyotrophic Lateral Sclerosis Pipeline constitutes 90+ key companies continuously working towards developing 100+ Amyotrophic Lateral
August 16, 2023
/PRNewswire/ -- DelveInsights Cough-assisted Devices Market Insights report provides the current and forecast market analysis, individual leading...
April 3, 2023
Celltrion and Genuv Inc., a Seoul-based a clinical-stage biotechnology company focused on drug discovery, entered a partnership last week to develop novel therapeutic antibodies using Genuv's SHINE MOUSE platform.
March 15, 2023
Cambridge, Massachusettes (PRWEB) March 15, 2023 -- SEOUL, Korea, Mar 14 (PR Web) – Genuv Inc., a clinical-stage biotechnology company focused on drug
February 21, 2023
The prevalence of amyotrophic lateral sclerosis has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of amyotrophic lateral
February 21, 2023
/PRNewswire/ -- DelveInsights Amyotrophic Lateral Sclerosis Pipeline Insight – 2023 report provides comprehensive global coverage of available, marketed,...
May 24, 2022
SEOUL, South Korea--(BUSINESS WIRE)--May 23, 2022--
June 10, 2021
Seoul, Korea (PRWEB) June 10, 2021 -- SEOUL, Korea, June 10 (PRWeb) – GENUV, Inc., a clinical stage biotechnology company focused on innovative drug discovery